SCHEMBL7570041

SCHEMBL7570041

Cc1ccc(-c2cc(C=O)ccc2C#N)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.47
MAOA P21397 6/20 0.44
MAOB P27338 5/20 0.44
AR P10275 2/20 0.43
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 3/20 0.41
HPGD P15428 3/20 0.41
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.41
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 1/20 0.41
PTK2B Q14289 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PDE3B Q13370 2/20 0.38
PDE3A Q14432 2/20 0.38
GALR3 O60755 1/20 0.38
GAA P10253 1/20 0.38
LRRK2 Q5S007 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7571095 0.83 ALDH1A1 (0.46) CYP2A6MAOAMAOBALDH1A1KDM4E
SCHEMBL7569318 0.83 AR (0.47) CYP2A6MAOAMAOBARALDH1A1
SCHEMBL7569312 0.81 CYP2A6 (0.40) CYP2A6MAOAMAOBARALDH1A1
SCHEMBL22560836 0.81 AR (0.51) CYP2A6MAOAMAOBARALDH1A1
SCHEMBL12457656 0.78 CYP2A6 (0.56) CYP2A6MAOAMAOBALDH1A1KDM4E
SCHEMBL7568349 0.77 CA1 (0.45) ARRAB9ACYP11B1CYP11B2
SCHEMBL24027812 0.76 TSHR (0.39) CYP2A6ARALDH1A1KDM4EHPGD
SCHEMBL7570617 0.76 AR (0.44) ARALDH1A1KDM4EHPGDGALR3
SCHEMBL7577589 0.76 KDM4E (0.43) MAOAMAOBARALDH1A1KDM4E
SCHEMBL18406715 0.76 ALDH1A1 (0.54) CYP2A6MAOAMAOBARALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors ABBOTT LABORATORIES 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors FNTA, FNTB, SLC10A1 CYP2A6 268/4885MAOA 2136/4885MAOB 1651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.